WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced that president and CEO Albert Luderer, Ph.D., will participate in the 19th Annual Piper Jaffray Health Care Conference in New York City on November 27. Following two global deals announced in the last three weeks – a marketing collaboration and licensing agreement with Applied Biosystems and a co-marketing agreement with Agilent – Dr. Luderer will provide an update on BioTrove’s growth in the areas of drug discovery, genomic research and molecular diagnostics technology.
